6-Bromo-2-fluoropyridin-3-ol, 95.0%, 25g

2,4,5-Trimethoxybenzoic acid, 95.0%, 500g

tert-Butyl (2S,5R)-2-ethyl-5-methylpiperazine-1-carboxylate, 95+%, 100mg

Polyvinyl alcohol, 100 g

N-[(3R)-Pyrrolidin-3-yl]-6-(trifluoromethyl)pyrimidin-4-amine dihydrochloride, 1g

(2,4-Dichlorobenzyl)triphenylphosphonium chloride, 97%, 25g

2-Fluoro-4-(methoxymethoxy)-1-methylbenzene, 98%, 10mg

2-N-Fmoc-Aminomethylpiperidine, 95.0%, 5g

Dimethylsiloxane-ethylene oxide, Polyalkylene oxide modified silicone cSt 100, 100g

tert-Butyl ((3S,4S)-7-cyano-4-methyl-2-oxo-2,3,4,5-tetrahydro-1H-benzo[b][1,4]diazepin-3-yl)carbamate, 98%, 1g

GC capillary column ROTI®Cap-5, 25 m, 0.32 mm, 3.00 µm, 1 Piece(s)

?-Cyclodextrin, 95%, 5g

ALPROSTADIL, 98%, 250mg